The Impact of Modern Anti-Diabetic Treatment on Endothelial Progenitor Cells

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2023 Nov 25

PMID 38002051

Authors

Velimir Altabas

Jelena Marinkovic Radosevic

Lucija Spoljarec

Stella Uremovic

Tomislav Bulum

Affiliations

Soon will be listed here.

Abstract

Diabetes is one of the leading chronic diseases globally with a significant impact on mortality. This condition is associated with chronic microvascular and macrovascular complications caused by vascular damage. Recently, endothelial progenitor cells (EPCs) raised interest due to their regenerative properties. EPCs are mononuclear cells that are derived from different tissues. Circulating EPCs contribute to regenerating the vessel's intima and restoring vascular function. The ability of EPCs to repair vascular damage depends on their number and functionality. Diabetic patients have a decreased circulating EPC count and impaired EPC function. This may at least partially explain the increased risk of diabetic complications, including the increased cardiovascular risk in these patients. Recent studies have confirmed that many currently available drugs with proven cardiovascular benefits have beneficial effects on EPC count and function. Among these drugs are also medications used to treat different types of diabetes. This manuscript aims to critically review currently available evidence about the ways anti-diabetic treatment affects EPC biology and to provide a broader context considering cardiovascular complications. The therapies that will be discussed include lifestyle adjustments, metformin, sulphonylureas, gut glucosidase inhibitors, thiazolidinediones, dipeptidyl peptidase 4 inhibitors, glucagon-like peptide 1 receptor analogs, sodium-glucose transporter 2 inhibitors, and insulin.

Citing Articles

Adjuvant Treatment with Empagliflozin or Semaglutide Increases Endothelial Progenitor Cells in Subjects with Well-Controlled Type 1 Diabetes Mellitus.

Preloznik Navodnik M, Rebersek K, Klinar K, Janez A, Podgornik H Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852169 PMC: 11764144. DOI: 10.3390/cimb47010054.

Exosome-based cell therapy for diabetic foot ulcers: Present and prospect.

Yang Z, Yang M, Rui S, Hao W, Wu X, Guo L Heliyon. 2024; 10(20):e39251.

PMID: 39498056 PMC: 11532254. DOI: 10.1016/j.heliyon.2024.e39251.

Swimming training promotes angiogenesis of endothelial progenitor cells by upregulating IGF1 expression and activating the PI3K/AKT pathway in type 2 diabetic rats.

Li L, Mang X, Jiang K, Zhao Y, Chen Y Mol Med Rep. 2024; 30(6).

PMID: 39422032 PMC: 11529167. DOI: 10.3892/mmr.2024.13361.

Mitochondrial Dysfunction in Endothelial Progenitor Cells: Unraveling Insights from Vascular Endothelial Cells.

Kulovic-Sissawo A, Tocantins C, Diniz M, Weiss E, Steiner A, Tokic S Biology (Basel). 2024; 13(2).

PMID: 38392289 PMC: 10886154. DOI: 10.3390/biology13020070.

References

Maiorino M, Bellastella G, Petrizzo M, Gicchino M, Caputo M, Giugliano D . Effect of a Mediterranean diet on endothelial progenitor cells and carotid intima-media thickness in type 2 diabetes: Follow-up of a randomized trial. Eur J Prev Cardiol. 2016; 24(4):399-408. DOI: 10.1177/2047487316676133. View

Rajasekar P, ONeill C, Eeles L, Stitt A, Medina R . Epigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular Complications. J Diabetes Res. 2015; 2015:436879. PMC: 4464584. DOI: 10.1155/2015/436879. View

Pearson J . Plasticity of adult endothelium: how frequent and to what extent?. Cardiovasc Res. 2015; 108(3):319-20. DOI: 10.1093/cvr/cvv240. View

Fullerton B, Jeitler K, Seitz M, Horvath K, Berghold A, Siebenhofer A . Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2014; (2):CD009122. PMC: 6486147. DOI: 10.1002/14651858.CD009122.pub2. View

Fadini G, Albiero M, Vigili de Kreutzenberg S, Avogaro A . Hypoglycemia affects the changes in endothelial progenitor cell levels during insulin therapy in type 2 diabetic patients. J Endocrinol Invest. 2015; 38(7):733-8. DOI: 10.1007/s40618-015-0247-1. View

Weech M, Altowaijri H, Mayneris-Perxachs J, Vafeiadou K, Madden J, Todd S . Replacement of dietary saturated fat with unsaturated fats increases numbers of circulating endothelial progenitor cells and decreases numbers of microparticles: findings from the randomized, controlled Dietary Intervention and VAScular function.... Am J Clin Nutr. 2018; 107(6):876-882. DOI: 10.1093/ajcn/nqy018. View

Aquino J, Sierra R, Montaldo L . Diverse cellular origins of adult blood vascular endothelial cells. Dev Biol. 2021; 477:117-132. DOI: 10.1016/j.ydbio.2021.05.010. View

Hess D, Terenzi D, Trac J, Quan A, Mason T, Al-Omran M . SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus. Cell Metab. 2019; 30(4):609-613. DOI: 10.1016/j.cmet.2019.08.015. View

Dyakova E, Kapilevich L, Shylko V, Popov S, Anfinogenova Y . Physical exercise associated with NO production: signaling pathways and significance in health and disease. Front Cell Dev Biol. 2015; 3:19. PMC: 4382985. DOI: 10.3389/fcell.2015.00019. View

10.

Fadini G, Mehta A, Dhindsa D, Bonora B, Sreejit G, Nagareddy P . Circulating stem cells and cardiovascular outcomes: from basic science to the clinic. Eur Heart J. 2020; 41(44):4271-4282. PMC: 7825095. DOI: 10.1093/eurheartj/ehz923. View

11.

Hortenhuber T, Rami-Mehar B, Satler M, Nagl K, Hobaus C, Hollerl F . Endothelial progenitor cells are related to glycemic control in children with type 1 diabetes over time. Diabetes Care. 2013; 36(6):1647-53. PMC: 3661838. DOI: 10.2337/dc12-1206. View

12.

Kazmierski M, Wojakowski W, Michalewska-Wludarczyk A, Podolecka E, Kotowski M, Machalinski B . Exercise-induced mobilisation of endothelial progenitor cells in patients with premature coronary heart disease. Kardiol Pol. 2015; 73(6):411-8. DOI: 10.5603/KP.a2014.0248. View

13.

Aoki A, Murata M, Asano T, Ikoma A, Sasaki M, Saito T . Prompt increases in retinol-binding protein 4 and endothelial progenitor cells during acute exercise load in diabetic subjects. Endocr J. 2012; 59(12):1085-91. DOI: 10.1507/endocrj.ej12-0192. View

14.

Benowitz N, Burbank A . Cardiovascular toxicity of nicotine: Implications for electronic cigarette use. Trends Cardiovasc Med. 2016; 26(6):515-23. PMC: 4958544. DOI: 10.1016/j.tcm.2016.03.001. View

15.

Zhu Z, Fu C, Li X, Song Y, Li C, Zou M . Prostaglandin E2 promotes endothelial differentiation from bone marrow-derived cells through AMPK activation. PLoS One. 2011; 6(8):e23554. PMC: 3158081. DOI: 10.1371/journal.pone.0023554. View

16.

Fadini G, De Kreutzenberg S, Albiero M, Coracina A, Pagnin E, Baesso I . Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol. 2008; 28(5):997-1004. DOI: 10.1161/ATVBAHA.107.159558. View

17.

Wilcox R, Kupfer S, Erdmann E . Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10). Am Heart J. 2008; 155(4):712-7. DOI: 10.1016/j.ahj.2007.11.029. View

18.

Yan F, Li J, Zhang W . Transplantation of Endothelial Progenitor Cells: Summary and prospect. Acta Histochem. 2023; 125(1):151990. DOI: 10.1016/j.acthis.2022.151990. View

19.

Chen L, Liao Y, Zeng T, Yu F, Li H, Feng Y . Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients. Endocrine. 2010; 38(2):266-75. DOI: 10.1007/s12020-010-9383-8. View

20.

Shannon O, Stephan B, Minihane A, Mathers J, Siervo M . Nitric Oxide Boosting Effects of the Mediterranean Diet: A Potential Mechanism of Action. J Gerontol A Biol Sci Med Sci. 2018; 73(7):902-904. DOI: 10.1093/gerona/gly087. View